Aiforia Technologies Secures Potential €20M EIB Venture Debt

Aiforia Technologies Oyj has reached an agreement with the European Investment Bank (EIB) on a non-binding indicative term sheet for up to €20 million in venture debt. This arrangement is structured in three tranches and contingent upon meeting revenue milestones within 36 months of a binding agreement. The tranches come with a three-year grace period and mature seven years after drawdown, featuring synthetic warrants granted to the EIB.

The EIB's involvement is significant, providing a degree of de-risking to Aiforia's funding outlook. Known for due diligence in funding projects in digitalisation and healthcare, the EIB's backing signals confidence in Aiforia's business model. This development alleviates concerns regarding the company's liquidity, extending their financial runway into Q3 2027 if the first tranche is drawn.

Despite the importance of this announcement, the term sheet remains non-binding. Further negotiations are required. The focus now is on the upcoming H1 report, with revenue as a central factor expected to impact share prices positively. Aiforia retains a BUY rating from analysts with a target price maintained at €3.80.